Glycopyrrolate Injection
Product Images NDC 62332-629

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 62332-629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate-1ml-carton (Glycopyrrolate 1ml Carton)

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL, an injectable solution for intramuscular or intravenous use. The label indicates 25 single-dose 1 mL vials per carton. It contains warnings such as 'Not for use in newborns' and 'Contains benzyl alcohol.' The product is Rx only and manufactured by Alembic Pharmaceuticals Inc.*

FDA Label Image

Glycopyrrolate-1ml-vial (Glycopyrrolate 1ml Vial)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, a 1 mL single-dose vial for intramuscular or intravenous use. Contains benzyl alcohol as a preservative. Manufactured for Alembic Pharmaceuticals, Inc. in India. Includes NDC 62332-607-01, lot and expiration date fields, and barcode.*

FDA Label Image

Glycopyrrolate-20ml-carton (Glycopyrrolate 20ml Carton)

Packaging label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL), a prescription injection for intramuscular or intravenous use. The label notes it contains benzyl alcohol and is not for use in newborns. It is labeled for 10 multiple-dose vials of 20 mL each, manufactured by Alembic Pharmaceuticals Inc.*

FDA Label Image

Glycopyrrolate-20ml-vial (Glycopyrrolate 20ml Vial)

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL (4 mg/20 mL) multiple-dose vial, manufactured for Alembic Pharmaceuticals Inc. The label states it is for intramuscular or intravenous administration, contains benzyl alcohol as a preservative, and includes storage instructions at 20° to 25°C. The label also notes it is not for use in newborns and provides NDC 62332-629-20.*

FDA Label Image

Glycopyrrolate-2ml-carton (Glycopyrrolate 2ml Carton)

Packaging label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) in 25 single-dose 2 mL vials. The label highlights it is not for use in newborns and contains benzyl alcohol. It is indicated for intramuscular or intravenous administration. Manufactured by Alembic Pharmaceuticals Inc.*

FDA Label Image

Glycopyrrolate-2ml-vial (Glycopyrrolate 2ml Vial)

Label for Glycopyrrolate Injection USP 0.4 mg/2 mL (0.2 mg/mL) single-dose vial for intramuscular or intravenous use. Contains benzyl alcohol, manufactured by Alembic Pharmaceuticals Inc., made in India. Includes lot and expiration date areas and a barcode.*

FDA Label Image

Glycopyrrolate-5ml-carton (Glycopyrrolate 5ml Carton)

Carton label for Glycopyrrolate Injection, USP 0.2 mg/mL (1 mg/5 mL) multiple-dose vials. The label indicates the product is for intramuscular or intravenous administration and contains benzyl alcohol. It is marked Rx only, not for use in newborns, and manufactured by Alembic Pharmaceuticals Inc. The carton is designed to hold 25 vials of 5 mL each.*

FDA Label Image

Glycopyrrolate-5ml-vial (Glycopyrrolate 5ml Vial)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL (1 mg/5 mL) in a 5 mL multiple-dose vial. The injection contains benzyl alcohol preservative and is for intramuscular or intravenous administration. Manufactured for Alembic Pharmaceuticals Inc., made in India. Storage instructions and other regulatory details are also included.*

FDA Label Image

Glycopyrrolate-structure (Glycopyrrolate Structure)

Chemical structure of Glycopyrrolate depicting its molecular configuration including phenyl, cyclopentyl, and quaternary ammonium bromide groups. This diagram visually represents the active ingredient Glycopyrrolate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.